SourceCF, Inc. was formed as a specialty pharmaceutical and medical company serving patients and families affected by cystic fibrosis, the healthcare providers committed to treating the disease, and the research organizations who are developing new and innovative treatments.

Company was acquired by Aptalis Pharmaceutical Technologies